Geneious Biologics Momentum Drives US, Europe and Asia Expansion for Biomatters

AUCKLAND, NZ – 18 July 2017- Bioinformatics software company Biomatters today announced it has opened new offices in Denmark and made key management appointments in North America, Europe and Asia to service growing demand from enterprises involved in biologic drug development. The announcement follows the recent launch of Biomatters’ Geneious Biologics solution, a highly scalable…

Read more

Geneious Biologics to Power Better Biological Drug Development

BIO-IT WORLD, BOSTON, MA – May 23, 2017 – Geneious Biologics, an enterprise software solution for screening antibodies and related constructs using sequence data, was launched today and will change the way scientists identify antibodies for use in biological drug development. The Geneious Biologics software platform will allow biopharma and biotechnology enterprises to create highly…

Read more

Geneious Biologics Set to Launch at BioIT World

AUCKLAND, NZ – April 18, 2017 – Geneious Biologics, a next-generation cloud service developed to empower enterprises engaged in commercial antibody discovery and screening and significantly improve their success rates, will launch at Bio-IT World Conference & Expo, in Boston MA, on May 23, 2017. The brainchild of bioinformatics technology company Biomatters, Geneious Biologics is…

Read more